Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs.$0.6M in Q1 2023; anticipating continued growth in 2024. Q1 2024 net loss: $3.8M vs.$7.0M in Q1 2023. Projected 2024 cash usage, excluding Lavie Bio and Biomica: $8.0M, down 36$12.5M in 2023. Ceasing Canonic's operations results in annualized savings of approximately $1.5 million. Casterra's new agreements with African and Brazilian castor seed growers secure 900 tons of castor ...